Cargando…
A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty
Central precocious puberty (CPP) is a diagnosis that pediatric endocrinologists worldwide increasingly make in girls of age 6-8 years and is mostly idiopathic. Part of the reason for increasing referral and diagnosis is the perception among the doctors as well as the patients that treatment of CPP w...
Autor principal: | Bereket, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790330/ https://www.ncbi.nlm.nih.gov/pubmed/29280737 http://dx.doi.org/10.4274/jcrpe.2017.S004 |
Ejemplares similares
-
Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015) -
Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018) -
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014) -
Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023) -
Effect of gonadotropin-releasing hormone analog treatment on final height in girls aged 6–10 years with central precocious and early puberty
por: Onat, Pınar Şimşek, et al.
Publicado: (2020)